Endpoints at #BIO24
Monday, June 3, 2024
7:00 AM -  12:00 PM PT 
Marriott Marquis
SAN DIEGO MARINA

Endpoints is back at BIO. The industry is descending on sunny San Diego with a sense of renewed optimism after a rough year. Just a few steps away from the convention center, we’re kicking off BIO with our exclusive networking breakfast lineup Monday morning. Join us for conversations about the ways US/China policy impacts biotech, gene therapy commercialization and lessons learned from last year — and find out who experts think is winning biotech's comeback.

Register to watch
Already registered? Request a login to access the recordings.

SPONSORED BY

Agenda-at-a-glance

Endpoints reporters and editors interview leading experts in biotech and beyond. More to come.

See Full agenda
  • 7:00 - 8:10am PT
    Networking breakfast
  • 8:10 - 8:15am PT
    Welcome remarks
  • 8:15 - 9:45am PT
    Series of interviews + panels
  • 9:45 - 10:00am PT
    Networking break
  • 10:00 - 11:45am PT
    Series of interviews + panels

Register to watch

  • Register to access all sessions for free.
Register now

Already registered

  • Receive an email to access all sessions for free.
Request login

Speakers

From our very own journalists to industry pioneers to thought leaders, all of our speakers bring unique expertise and insight to the stage.

Lynn Seely
President & CEO
Lyell Immunopharma
Lynn Seely
Andrew Lam
Managing Director, Head of Biotech Private Equity
Ally Bridge Group
Andrew Lam
Kurt von Emster
Managing Partner, Head of Life Sciences
Abingworth
Kurt von Emster
Jami Rubin
Chief Financial Officer
Boundless Bio
Jami Rubin
Tim Opler
Managing Director
Stifel
Tim Opler
Nick Shipley
Former Chief Advocacy Officer, BIO
Biopharma Consultant, Former BIO and PhRMA Senior Executive
Nick Shipley
Helen Chen
Global Sector Co-Head, Healthcare and Life Sciences | Greater China Managing Partner
L.E.K. Consulting
Helen Chen
Aviv Regev
Executive VP, Head of Genentech Research & Early Development (gRED)
Genentech
Aviv Regev
Tom Klima
Chief Commercial & Operating Officer
bluebird bio
Tom Klima
Matt Gline
CEO
Roivant Sciences
Matt Gline
Bill Newell
CEO
Sutro Biopharma
Bill Newell
Geeta Vemuri
Founder & Managing Partner
Agent Capital
Geeta Vemuri
Philippe Lopes-Fernandes
Executive VP, Chief Business Officer
Ipsen
Philippe Lopes-Fernandes
Sung Hee Choe
Managing Director for FasterCures
Milken Institute
Sung Hee Choe
Svetlana Lucas
Chief Business Officer
Scribe Therapeutics
Svetlana Lucas

Moderators

Andrew Dunn
Senior Biopharma Correspondent
Endpoints News
Andrew Dunn
Drew Armstrong
Executive Editor
Endpoints News
Drew Armstrong
John Carroll
Founder & Editor
Endpoints News
John Carroll
Amber Tong
Senior Editor
Endpoints News
Amber Tong